E-LIB Suche - Ergebnisse für: Locke, Frederick

1

Safety and efficacy of anti-BCMA CAR-T cell therapy in olde..:

Akhtar, Othman Salim ; Sheeba, Ba Aqeel ; Azad, Farhan...
Journal of Geriatric Oncology. 15 (2024) 2 - p. 101628 , 2024

Link: https://doi.org/10.1016/..

2

Bridging therapy with axicabtagene ciloleucel for large B-c..:

Jain, Michael D. ; Jacobs, Miriam T. ; Gao, Feng...
Blood Advances. 8 (2024) 4 - p. 1042-1050 , 2024

Link: https://doi.org/10.1182/..

3

A Cost-Effectiveness Analysis of Axicabtagene Ciloleucel Ve..:

Locke, Frederick L. ; Ray, Mark ; Hasegawa, Ken...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S366-S367 , 2024

Link: https://doi.org/10.1016/..

4

Applying the EHA/EBMT grading for ICAHT after CAR-T: compar..:

Rejeski, Kai ; Wang, Yucai ; Hansen, Doris K....
Blood Advances. 8 (2024) 8 - p. 1857-1868 , 2024

Link: https://doi.org/10.1182/..

5

Identification of Pre-Treatment Clinical Risk Factors Predi..:

Geethakumari, Praveen Ramakrishnan ; Wudhikarn, Kitsada ; Jain, Michael D....
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S358-S359 , 2024

Link: https://doi.org/10.1016/..

6

Racial and ethnic differences in clinical outcomes among pa..:

Peres, Lauren C. ; Oswald, Laura B. ; Dillard, Christen M....
Blood Advances. 8 (2024) 1 - p. 251-259 , 2024

Link: https://doi.org/10.1182/..

7

Real-world impact of bridging therapy on outcomes of ide-ce..:

Afrough, Aimaz ; Hashmi, Hamza ; Hansen, Doris K....
Blood Cancer Journal. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

8

Outcomes of Haploidentical Stem Cell Transplant Recipients ..:

Yepes, Amanda ; Faramand, Rawan G ; Bejanyan, Nelli...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S439 , 2024

Link: https://doi.org/10.1016/..

9

Absolute Lymphocyte Count and Outcomes of Multiple Myeloma ..:

Khouri, Jack ; Dima, Danai ; Li, Hong...
Transplantation and Cellular Therapy. , 2024

Link: https://doi.org/10.1016/..

10

Expanded Antigen-Specific Donor Regulatory T Cells for Gvhd..:

Pidala, Joseph A. ; Betts, Brian C. ; Schell, Michael...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S27-S28 , 2024

Link: https://doi.org/10.1016/..

11

Impact of extramedullary multiple myeloma on outcomes with ..:

Zanwar, Saurabh ; Sidana, Surbhi ; Shune, Leyla...
Journal of Hematology & Oncology. 17 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

12

Real-World Tisagenlecleucel Outcomes in Richter-Transformed..:

Shadman, Mazyar ; Frigault, Matthew J. ; Foley, Stephen Ronan...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S189-S190 , 2024

Link: https://doi.org/10.1016/..

13

Benefit of axicabtagene ciloleucel versus chemoimmunotherap..:

Lunning, Matthew A. ; Wang, Hai‐lin ; Hu, Zhen‐Huan...
American Journal of Hematology. 99 (2024) 5 - p. 880-889 , 2024

Link: https://doi.org/10.1002/..

14

Minority Patients Receiving CAR T Therapy in the US between..:

Goldfinger, Mendel ; Hu, Zhen-Huan ; Rapoport, Aaron P....
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S321 , 2024

Link: https://doi.org/10.1016/..

15

Chimeric Antigen Receptor T-Cell Therapy in the Outpatient ..:

Oluwole, Olalekan O. ; Dholaria, Bhagirathbhai ; Knight, Tristan E....
Transplantation and Cellular Therapy. 30 (2024) 2 - p. 131-142 , 2024

Link: https://doi.org/10.1016/..